Taken together, the combined Drosophila Ras and Src co-activated tumor model, as well as the feeding-based obesity model, have provided new mechanistic insights into how tumors tune their metabolism to take advantage of increased insulin and glucose levels, and to thrive in conditions of organismal insulin resistance. Here, INS is linked to neoplasm.